Radiofrequency Ablation of Uterine Fibroids
Stopped early · Early Phase 1
Conditions studied: Uterine Fibroids
In brief
This research study is being conducted to evaluate the safety and effectiveness of ablation (destruction) of uterine leiomyomas (fibroids) using electrocautery heating guided by ultrasound. We are doing this to look for a less invasive method of treatment for patients with uterine fibroids. One method that is being used in other areas of the body to treat masses is radiofrequency electrocautery. This method may be performed for the treatment of uterine fibroids by placing a small diameter needle through the wall of the vagina into the fibroid guided by an ultrasound probe. An optional approach is to place the needle through the skin of the abdomen into the fibroid guided by an ultrasound probe. Once the needle is in the fibroid, the electrocautery current is applied and the fibroid is destroyed by heating. This would be done before hysterectomy (removal of the uterus). We are trying to test to see if this type of treatment can be applied to uterine fibroids. We are trying to develop radiofrequency electrocautery as one of the methods to treat fibroids without surgery.
Key facts
- Study ID
- NCT00584207
- Run by
- University of California, Davis
- People needed
- 15
- Starts
- 2004-03-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2009-04-23
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age or older
- Diagnosed with uterine leiomyomas (fibroids)
- Patient will undergo surgical hysterectomy
- Patient is willing to sign informed consent form
You may not qualify if…
- Patients with acute infection
- Patients with bleeding disorders
- Patients who are not candidates for surgery or general anesthesia
Where it is running
- UC Davis Medical Center — Sacramento, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.